ADARx Pharmaceuticals files for Nasdaq Global Market IPO under ADRX
ADARx Pharmaceuticals, a late-clinical stage siRNA therapeutics developer, filed for an initial public offering and plans to list on the Nasdaq Global Market under ticker ADRX.
Story updates
09:33:05 PM UTC
SquawkNews
Adarx Pharmaceuticals Announces Initial Public Offering Of Common Stock, SEC Filing
ADARx Pharmaceuticals, a late-clinical stage biotechnology company focused on next—generation siRNA therapeutics, filed for an initial public offering.
The company plans to list on the Nasdaq Global Market under the ticker "ADRX." Proceeds will support multiple clinical programs, including compleme…